当前位置:首页 - 行情中心 - 南新制药(688189) - 财务分析 - 现金流量表

南新制药

(688189)

  

流通市值:42.31亿  总市值:42.31亿
流通股本:2.74亿   总股本:2.74亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金164,459,677.19123,671,872.07306,289,354.29257,971,161.66
  收到的税费返还12,771.71-196,743.08-
  收到其他与经营活动有关的现金16,153,936.813,971,867.4713,345,941.512,103,123.17
  经营活动现金流入小计180,626,385.7137,643,739.54319,832,038.87270,074,284.83
  购买商品、接受劳务支付的现金19,459,516.167,292,061.2872,676,854.4768,545,645.46
  支付给职工以及为职工支付的现金27,397,524.114,723,320.3475,969,327.7955,752,438.1
  支付的各项税费5,846,837.492,383,950.2440,887,216.2440,924,775.62
  支付其他与经营活动有关的现金45,646,876.1213,906,302.83128,905,150.2674,742,143.85
  经营活动现金流出小计98,350,753.8738,305,634.69318,438,548.76239,965,003.03
  经营活动产生的现金流量净额82,275,631.8399,338,104.851,393,490.1130,109,281.8
二、投资活动产生的现金流量:
  取得投资收益收到的现金--851,111.11-
  处置固定资产、无形资产和其他长期资产收回的现金净额2,938,741.45-1,884,393.6-
  收到的其他与投资活动有关的现金--100,000,000100,458,904.11
  投资活动现金流入的平衡项目0-00
  投资活动现金流入小计2,938,741.45-102,735,504.71100,458,904.11
  购建固定资产、无形资产和其他长期资产支付的现金63,872,061.338,982,772.2858,425,846.7334,043,257.3
  支付其他与投资活动有关的现金150,000,000150,000,000-79,452.05
  投资活动现金流出小计213,872,061.3188,982,772.2858,425,846.7334,122,709.35
  投资活动产生的现金流量净额-210,933,319.85-188,982,772.2844,309,657.9866,336,194.76
三、筹资活动产生的现金流量:
  取得借款收到的现金--119,000,000-
  收到其他与筹资活动有关的现金--103,572,609.973,572,609.97
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--222,572,609.973,572,609.97
  偿还债务支付的现金70,000,000-323,800,000258,800,000
  分配股利、利润或偿付利息支付的现金--5,226,482.993,171,583.3
  支付其他与筹资活动有关的现金2,227,871.66259,70410,708,383.1611,269,226.52
  筹资活动现金流出小计72,227,871.66259,704339,734,866.15273,240,809.82
  筹资活动产生的现金流量净额-72,227,871.66-259,704-117,162,256.18-269,668,199.85
五、现金及现金等价物净增加额-200,885,559.68-89,904,371.43-71,459,108.09-173,222,723.29
  加:期初现金及现金等价物余额490,270,275.37490,270,275.37561,729,383.46561,729,383.46
  期末现金及现金等价物余额289,384,715.69400,365,903.94490,270,275.37388,506,660.17
补充资料:
  净利润-43,826,515.3--397,273,855.83-
  资产减值准备3,555,852.62-41,297,260.04-
  固定资产和投资性房地产折旧9,928,006.42-21,644,978.05-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧9,928,006.42-21,644,978.05-
  无形资产摊销8,160,979.78-15,818,025.69-
  长期待摊费用摊销19,025.39-712,458.91-
  处置固定资产、无形资产和其他长期资产的损失---594,628.23-
  财务费用1,448,716.65-5,401,505.42-
  投资损失275,386.3---
  递延所得税-129,469.06-5,619,004.03-
  其中:递延所得税资产减少-24,278.18-6,098,823.85-
    递延所得税负债增加-105,190.88--479,819.82-
  存货的减少7,369,859.2--29,625,996.9-
  经营性应收项目的减少120,486,584.89-65,902,520.69-
  经营性应付项目的增加-35,807,719.48--11,895,012.7-
  现金的期末余额289,384,715.69-490,270,275.37-
  减:现金的期初余额490,270,275.37-561,729,383.46-
  现金及现金等价物的净增加额-200,885,559.68--71,459,108.09-
公告日期2025-08-292025-04-302025-04-302024-10-31
审计意见(境内)标准无保留意见
TOP↑